Published in Neurosci Lett on August 19, 1991
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell (2011) 3.28
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation (2008) 3.19
Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A (1995) 2.24
Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol (2007) 2.05
A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci U S A (1999) 1.90
Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol Dis (2009) 1.60
Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol (1995) 1.53
Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons. Proc Natl Acad Sci U S A (2004) 1.46
Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J Neuroinflammation (2008) 1.45
Oxidative stress and ageing: is ageing a cysteine deficiency syndrome? Philos Trans R Soc Lond B Biol Sci (2005) 1.41
The kynurenine system and immunoregulation. J Neural Transm (Vienna) (2011) 1.38
Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamm (2014) 1.35
TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflammation (2012) 1.29
Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed Res Int (2013) 1.25
The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch Immunol Ther Exp (Warsz) (2012) 1.23
Inflammatory process in Alzheimer's Disease. Front Integr Neurosci (2013) 1.10
Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol (1993) 1.09
Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription. Biochem J (2004) 1.04
Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain. Am J Pathol (2011) 1.02
Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events. Neurobiol Dis (2013) 1.02
Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology. Brain (2016) 1.01
Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models. J Neuroinflammation (2010) 1.01
Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades. J Neuroinflammation (2010) 1.00
Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation. J Alzheimers Dis (2010) 1.00
Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview. Mol Neurobiol (2014) 0.98
Genetic risk factors in Alzheimer's disease. Mol Pathol (1998) 0.97
Transforming growth factor beta in Alzheimer's disease. Clin Diagn Lab Immunol (1994) 0.96
Effects of TNFalpha-converting enzyme inhibition on amyloid beta production and APP processing in vitro and in vivo. J Neurosci (2008) 0.95
Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons. FASEB J (2011) 0.95
The role of inflammasome in Alzheimer's disease. Ageing Res Rev (2014) 0.95
Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-alpha. J Cell Biol (2001) 0.92
Current treatment and recent clinical research in Alzheimer's disease. Mt Sinai J Med (2010) 0.92
Inflammatory cytokines IL-1β and TNF-α regulate p75NTR expression in CNS neurons and astrocytes by distinct cell-type-specific signalling mechanisms. ASN Neuro (2009) 0.91
The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain. J Pharm Pharmacol (Los Angel) (2013) 0.88
TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease. J Neural Transm (Vienna) (2006) 0.87
miR-155 is involved in Alzheimer's disease by regulating T lymphocyte function. Front Aging Neurosci (2015) 0.86
Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer's disease. PLoS One (2015) 0.85
Amyloid-β reduces the expression of neuronal FAIM-L, thereby shifting the inflammatory response mediated by TNFα from neuronal protection to death. Cell Death Dis (2015) 0.85
Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms. Saudi J Biol Sci (2014) 0.84
Cardiovascular dementia - a different perspective. Open Biochem J (2010) 0.83
Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways. Neurobiol Aging (2013) 0.83
Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation (2010) 0.82
Chronic neuron- and age-selective down-regulation of TNF receptor expression in triple-transgenic Alzheimer disease mice leads to significant modulation of amyloid- and Tau-related pathologies. Am J Pathol (2013) 0.82
Cytokine networks in neuroinflammation. Nat Rev Immunol (2016) 0.81
Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer's disease. J Inflamm Res (2008) 0.81
The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms. Exp Brain Res (2014) 0.81
Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity. Neural Plast (2016) 0.80
The effect of chronic periodontitis on serum levels of tumor necrosis factor-alpha in Alzheimer disease. Dent Res J (Isfahan) (2014) 0.80
6-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation. J Neuroinflammation (2016) 0.79
Neural stem/progenitor cells in Alzheimer's disease. Yale J Biol Med (2016) 0.78
Alzheimer's Disease: Exploring the Role of Inflammation and Implications for Treatment. Int J Alzheimers Dis (2015) 0.78
Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran. J Res Med Sci (2011) 0.78
Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers. J Neurosci (2016) 0.77
The Distinct Role of ADAM17 in APP Proteolysis and Microglial Activation Related to Alzheimer's Disease. Cell Mol Neurobiol (2015) 0.76
Selective induction of alternatively spliced FynT isoform by TNF facilitates persistent inflammatory responses in astrocytes. Sci Rep (2017) 0.75
Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration. Front Aging Neurosci (2017) 0.75
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation. Nanomedicine (2016) 0.75
Amyloid Beta, TNFα and FAIM-L; Approaching New Therapeutic Strategies for AD. Front Neurol (2014) 0.75
Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain. Acta Neuropathol Commun (2016) 0.75
Heparan sulfate proteoglycan induces the production of NO and TNF-alpha by murine microglia. Immun Ageing (2005) 0.75
CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection. Biomed Res Int (2016) 0.75
Gene expression profiles and protein-protein interaction networks in amyotrophic lateral sclerosis patients with C9orf72 mutation. Orphanet J Rare Dis (2016) 0.75
The Role of Hypoxia-Inducible Factor 1 in Mild Cognitive Impairment. Cell Mol Neurobiol (2016) 0.75
TNFα affects CREB-mediated neuroprotective signaling pathways of synaptic plasticity in neurons as revealed by proteomics and phospho-proteomics. Oncotarget (2017) 0.75
Tumor necrosis factor α Inhibition for Alzheimer's Disease. J Cent Nerv Syst Dis (2017) 0.75
Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders. PLoS One (2017) 0.75
The renin-angiotensin system: a possible new target for depression. BMC Med (2017) 0.75
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med (1990) 5.65
Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature (1996) 5.50
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet (1997) 4.11
Clathrin-coated vesicles contain an ATP-dependent proton pump. Proc Natl Acad Sci U S A (1983) 2.84
The attitudes and practices of general practitioners regarding dementia diagnosis in Ireland. Int J Geriatr Psychiatry (2008) 1.80
Determination of normal ear temperature with an infrared emission detection thermometer. Ann Emerg Med (1995) 1.60
Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation (1999) 1.59
Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery (1998) 1.54
Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr (2003) 1.46
Fusion of coated vesicles with lysosomes: measurement with a fluorescence assay. Cell (1983) 1.39
Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry (2011) 1.11
Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 1.04
Association studies of 23 positional/functional candidate genes on chromosome 10 in late-onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2007) 0.98
CSF homovanillic acid in schizotypal personality disorder. Am J Psychiatry (1993) 0.97
Effects of S-nitrosoglutathione on acute vasoconstriction and glutamate release after subarachnoid hemorrhage. Stroke (1999) 0.96
A Multiple Indicators Multiple Causes (MIMIC) model of Behavioural and Psychological Symptoms in Dementia (BPSD). Neurobiol Aging (2009) 0.94
Selective catheter ablation of the tachycardia focus in patients with nonreentrant junctional tachycardia. Am J Cardiol (1996) 0.94
Comparing sediment quality in Spanish littoral areas affected by acute (Prestige, 2002) and chronic (Bay of Algeciras) oil spills. Environ Pollut (2006) 0.92
Biochemical effects of PR toxin on rat liver mitochondrial respiration and oxidative phosphorylation. Arch Biochem Biophys (1984) 0.91
Hypouricemia, abnormal renal tubular urate transport, and plasma natriuretic factor(s) in patients with Alzheimer's disease. J Am Geriatr Soc (1993) 0.90
Enrichment of presenilin 1 peptides in neuronal large dense-core and somatodendritic clathrin-coated vesicles. J Neurochem (1998) 0.90
Predictors of hospital length of stay and nursing home placement in an elderly medical population. J Am Med Dir Assoc (2003) 0.89
A feminist perspective on the study of home birth. Application of a midwifery care framework. J Nurse Midwifery (1994) 0.88
Byproducts of anaerobic alkylbenzene metabolism useful as indicators of in situ bioremediation. Environ Sci Technol (1995) 0.86
Structural and mode of action studies on the antibiotic vancomycin. Evidence from 270-MHz proton magnetic resonance. J Am Chem Soc (1977) 0.86
Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure. J Am Coll Cardiol (2000) 0.86
A pilot study of prednisone in Alzheimer's disease. Dementia (1997) 0.85
A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. J Cardiothorac Vasc Anesth (1997) 0.84
The safety and efficacy of electroconvulsive therapy in patients over age 75. Int J Geriatr Psychiatry (1998) 0.83
Determination of naphthalenesulfonic acid isomers by large-volume on-line derivatization and gas chromatography-mass spectrometry. J Chromatogr A (2001) 0.82
Sediment contamination, bioavailability and toxicity of sediments affected by an acute oil spill: Four years after the sinking of the tanker Prestige (2002). Chemosphere (2008) 0.82
Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses. Heart (1997) 0.82
Full and fractionated experimental designs for robustness testing in the high-performance liquid chromatographic analysis of codeine phosphate, pseudoephedrine hydrochloride and chlorpheniramine maleate in a pharmaceutical preparation. J Chromatogr A (2000) 0.81
The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis (1998) 0.81
Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure. Am J Cardiol (1996) 0.81
Hereditary spastic paraparesis and psychosis. Eur J Neurol (2006) 0.80
Mental health expectancy--the European perspective: a synopsis of results presented at the Conference of the European Network for the Calculation of Health Expectancies (Euro-REVES). Medical Research Council Cognitive Function and Ageing Study Group. Acta Psychiatr Scand (1998) 0.80
A protective effect of apolipoprotein E e2 allele on dementia in Down's syndrome. Biol Psychiatry (1998) 0.80
Association of HLA class II alleles in patients with juvenile myoclonic epilepsy compared with patients with other forms of adolescent-onset generalized epilepsy. Neurology (1996) 0.80
Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure. Am Heart J (1999) 0.79
Source and impact of lead contamination on δ-aminolevulinic acid dehydratase activity in several marine bivalve species along the Gulf of Cadiz. Aquat Toxicol (2010) 0.78
A pilot study of the reliability and validity of the Caregiver Activity Survey - Intellectual Disability (CAS-ID). J Intellect Disabil Res (2002) 0.78
Reporting vaccine-associated adverse events. Can Fam Physician (1997) 0.78
Are alpha-1-antichymotrypsin and inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease? J Neurol Neurosurg Psychiatry (1991) 0.78
Cimetidine-induced mental confusion in elderly. N Y State J Med (1980) 0.77
Comparison of the differences in cephalometric parameters after active orthodontic treatment applying mini-screw implants or transpalatal arches in adult patients with bialveolar dental protrusion. J Oral Rehabil (2009) 0.77
The imperative for disease modifying treatments in Alzheimer's disease. Ir Med J (2009) 0.77
An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels. Exp Neurol (2009) 0.76
Late onset Alzheimer's disease and apolipoprotein association in the Irish population: relative risk and attributable fraction. Ir J Med Sci (2003) 0.76
Elevated alpha 1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer's disease patients. Dementia (1995) 0.76
Correction. NILVAD protocol: a European multicenter double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease. BMJ Open (2015) 0.75
'The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia'--1997, 12, 519-527. Int J Geriatr Psychiatry (1998) 0.75
Quinapril-associated acute psychosis in an older woman. J Am Geriatr Soc (2000) 0.75
A strategy of "combination chemotherapy" in Alzheimer's disease: rationale and preliminary results with physostigmine plus deprenyl. Int Psychogeriatr (1992) 0.75
Doppler pulse waveform analysis of carotid and middle cerebral artery flow in a patient with an intra-aortic balloon pump. J Neuroimaging (1999) 0.75
Presenilin 1 and alpha-1-antichymotrypsin polymorphisms in Down syndrome: no effect on the presence of dementia. Am J Med Genet (1999) 0.75
Tissue plasminogen activator: the nurse's role. Crit Care Nurse (1994) 0.75
Contrasting child and adolescent psychiatry services in Szeged, Hungary, and Glasgow, Scotland. Eur Child Adolesc Psychiatry (1998) 0.75
Automatic memory processes in patients with dementia-Alzheimer's type (DAT). Cortex (1990) 0.75
Substrate specificity of human platelet monoamine oxidase B activity Parkinson's and Alzheimer's disease. Biochem Soc Trans (1996) 0.75
Radiofrequency catheter ablation of tachyarrhythmias--adult and paediatric experience. Aust N Z J Med (1993) 0.75
Stimulation of prostacyclin formation by the platelet-derived growth factor--an important pathomechanism for atherogenesis? Exp Pathol (1988) 0.75
[Cardiac cephalgia]. Zhonghua Nei Ke Za Zhi (2017) 0.75
Association analysis of dynamin-binding protein (DNMBP) on chromosome 10q with late onset Alzheimer's disease in a large caucasian UK sample. Am J Med Genet B Neuropsychiatr Genet (2009) 0.75
Senile dementia and apolipoprotein E4. Dement Geriatr Cogn Disord (1997) 0.75
Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusion. Oncology (1989) 0.75
Electrical mapping in combination with intracardiac ultrasound for electrical-anatomic correlation. J Electrocardiol (1998) 0.75
Alcohol and heart disease--what do you prescribe? Ir Med J (2005) 0.75
Effect of race in the response to metoprolol in patients with congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol (1997) 0.75
Nongonococcal urethritis incidence has fallen at one university health service: are "safer sex" messages being heard? Sex Transm Dis (1990) 0.75